diflucortolone valerate has been researched along with Anasarca in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizoğlu, E; Özcan, I; Özer, Ö; Özyazıcı, M; Senyiğit, T | 1 |
| Ishii, T; Kai, H; Kakuta, T; Kibushi, N; Kijima-Suda, I; Miyata, T; Nakajima, T; Sato, C; Sugai, K; Tanaka, N | 1 |
2 other study(ies) available for diflucortolone valerate and Anasarca
| Article | Year |
|---|---|
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Chitosan; Diflucortolone; Drug Carriers; Edema; Gels; Lecithins; Male; Mechanical Phenomena; Nanoparticles; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption; Vasoconstriction | 2013 |
Local anti-inflammatory activity and systemic side effects of NM-135, a new prodrug glucocorticoid, in an experimental inflammatory rat model.
Topics: Animals; Anti-Inflammatory Agents; Atrophy; Betamethasone Valerate; Croton Oil; Diflucortolone; Disease Models, Animal; Dose-Response Relationship, Drug; Ear; Edema; Exudates and Transudates; Glucocorticoids; Granuloma; Inflammation; Male; Organ Size; Pregnanediones; Prodrugs; Rats; Rats, Sprague-Dawley; Thymus Gland | 1998 |